Tian Zhigang, China

advertisement

Zhigang Tian, M.D., Ph.D

.

Professor & Director, Institute of Immunology

University of Science & Technology of China

443 Huangshan Street, Hefei City, Anhui 230027, P.R.China

Tel:(551) 360-0845 ; 360-7379 (Sectarian); 3607377(Lab)

Fax: (551) 360-6783; E.mail: tzg@ustc.edu.cn;

Education and Appointment

05/2001–present: Professor, Univ Sci Tech China, China

04/1989-05/2001: Assist/Asso/Full Professor, Shandong Acad Med Sci, China

03/1986-03/1989: Ph.D., Immunology, Normal Bethune Med Univ, China.

03/1983-08/1985: M.S.,Immunol,Shandong Acad Med Sci, China

03/1978-12/1982: M.D., Shanxi Medical University, China

05/2002–04/2003: Visiting Professor, Kanazawa Univ Cancer Inst, Japan

1/2002–4/2002, Visiting Scientist, NIAAA, NIH, USA

2/1999–8/1999: Visiting Professor, Med College Virginia, Richmond, USA

8/1994-6/1996: Visiting Scientist, NCI, NIH, USA

Speciality & Research Field of Interest

NK cells, liver immunology and major diseases (cancer, infection and autoimmunity)

Resent Selective Publications

1. Han QJ, Zhang C, Zhang J, Tian ZG. Reverse of HBV-induced immune tolerance by an immunostimulatory 3p-HBx-siRNA in a retinoic acid inducible gene I (RIG-I) -dependent manner. Hepatology 2011 , in press.

2.

Jin Z, Sun R, Wei H, Gao X, Chen Y, Tian Z. Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells. Hepatology. 2010 ; 53:219-29

3.

Hou X, Zhou R, Wei H, Sun R, Tian Z. NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis. Hepatology 2009 , 49:940-9

4.

Gao B, Jeong WI, Tian Z. Liver: An organ with predominant innate immunity.

Hepatology. 2008 ; 47:729-36.

5.

Chen QF, Wei HM, Sun R, Zhang J, Tian Z. Therapeutic RNA silencing of Cys-X3-Cys chemokine ligand 1 gene prevents mice from adenovirus vector-induced acute liver injury.

Hepatology 2008 , 47:648-58

6.

Chen Y, Wei H, Sun R, Dong Z, Zhang J, Tian Z. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology. 2007 ; 46(3):706-15.

7.

Zhou R, Wei H, Sun R, Tian ZG. NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice

Proc Natl Acad Sci U S A. 2007 ; 104(18):7512-5.

8.

Dong Z, Zhang J, Sun S, Wei H, Tian ZG. Impairment of liver regeneration correlates with over-activated hepatic NKT cells in HBV transgenic mice. Hepatology 2007;

45(6):1400-12.

1

9.

Li B, Sun R, Wei H, Gao B, Tian ZG. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism. Hepatology. 2006 ;

43(6):1211-9.

10.

Jiang W, Sun R, Wei HM, Tian ZG. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. Proc

Natl Acad Sci USA 2005 ; 102 (47): 17077-17082.

2

Download